Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Sensus Healthcare Community
NasdaqCM:SRTS Community
2
Narratives
written by author
1
Comments
on narratives written by author
93
Fair Values set
on narratives written by author
Create a narrative
Sensus Healthcare
Popular
Undervalued
Overvalued
Community Investing Ideas
Sensus Healthcare
NA
NateF
Community Contributor
SRTS Market Outlook
Sensus Healthcare, Inc. (NASDAQ: SRTS) specializes in non-invasive treatments for skin conditions, notably through its Superficial Radiation Therapy (SRT) technology.
View narrative
US$13.42
FV
65.6% undervalued
intrinsic discount
20.39%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
43
users have followed this narrative
3 months ago
author updated this narrative
Sensus Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
International Expansion And New Verticals Will Diversify Future Revenues
Key Takeaways Expanding international sales and entering new verticals indicate potential revenue growth through untapped markets and additional revenue channels. Strong cash position with no debt supports continued investment in R&D and sales, crucial for enhancing future earnings.
View narrative
US$12.00
FV
61.6% undervalued
intrinsic discount
14.53%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
34
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
SRTS
SRTS
Sensus Healthcare
Your Fair Value
US$
Current Price
US$4.61
21.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-7m
77m
2015
2018
2021
2024
2025
2027
2030
Revenue US$76.5m
Earnings US$12.2m
Advanced
Set Fair Value